Prednisone

Prednisone Reactions 1680, p283 - 2 Dec 2017 Fatal disseminated Nocardia farcinica bacteraemia: case report A 91-year-old man developed fatal disseminated Nocardia farcinica bacteraemia following treatment with prednisone [route not stated]. The man was admitted with a complaints of fatigue, anorexia, weight loss of 10kg in few weeks and arthralgia, on July 2012. He had a history of myelodysplastic syndrome (MDS), complicated by autoimmune haemolytic anaemia since March 2012. He was on treatment with prednisone 25 mg/day, cutting down the dosage by half every week to treat MDS. Few days prior to the admission, he had completed his prednisone therapy. On admission, his examination revealed a low-grade fever, fatigue, non-productive cough, bilateral basal crackles and wheezes at chest auscultation. His blood pressure was at 118/78mm Hg, heart rate was 82 beats/minute, respiratory rate was 20 breaths/minute and oxygen saturation was 95%. Two sets of blood cultures were drawn from the different peripheral sites at the same time. Laboratory tests revealed haemoglobin level at 10.2 g/dL, leucocytes count at 11.3×10 /µL, platelet count at 202×10 /µL, sedimentation rate of 42 mm/h, creatinine level at 1.95 mg/dL, albumin level at 2.7 g/dL and gamma globulin level of 29.5% with two monoclonal bands in gamma region. A chest X-ray demonstrated multiple nodular acinar opacities in both lungs with diffuse interstitial thickening. A presumptive diagnosis of community-acquired pneumonia was made. The man was treated with ceftriaxone. Despite treatment, his condition slightly worsened over the next couple of days. The level of consciousness decreased and he experienced low- grade fever episodes every day. On day 4, the aerobic bottle of the first blood culture was found to be positive. Gram staining of positive bottle showed branching Gram-positive rods. On the basis of these findings, Nocardia spp. bacteraemia was suspected. His ceftriaxone therapy was switched to cotrimoxazole [trimethoprim/sulfamethoxazole] and linezolid. The positive blood culture was subcultured and incubated. Two days later, very small colonies were observed on Columbia blood agar and were identified by MALDITOF MS as Nocardia farcinica, with a score of 1.879. On day 5, N. farcinica identification was confirmed by conventional biochemical tests. Ciprofloxacin was added to the therapy. On day 10, his level of consciousness deteriorated to a state of light coma, difficult to awaken, with worsened shortness of breath. Oxygen saturation was 89%, hence, oxygen therapy was initiated via nasal cannula. A brain CT scan revealed multiple enhancing focal lesions in the frontal regions, midbrain and in the cerebellum. A chest CT scan revealed multiple nodular lesions and bilateral pleural effusion. However, he was suffering from psychosis and was in coma, was uncooperative when awakened. Hence, thoracentesis could not be performed. On day 18 of hospitalisation, he died due to Nocardia farcinica bacteraemia. Author comment: "Most of the patients with N. farcinica infection had predisposing factors like hematologic malignancies, treatment with corticosteroids, solid tumors, bone marrow or solid organ transplantation, HIV infection, chronic pulmonary, and renal diseases." Leli C, et al. Fatal nocardia farcinica bacteremia diagnosed by matrix-assisted laser desorption-ionization time of flight mass spectrometry in a patient with myelodysplastic syndrome treated with corticosteroids. Case Reports in Medicine 2013: 16 Apr 2013. Available from: URL: http://doi.org/10.1155/2013/368637 - Italy 803284495 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Prednisone

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/prednisone-ebmdLa00ca
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39214-6
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial